Indication
Vaccination
Aliases
Vaccination; Infection
16 clinical trials
21 products
Clinical trial
"Multicenter Observational Study to Assess the Incidence and Features of COVID-19 and the Response to COVID-19 Vaccination in Fragile Patients"Status: Active (not recruiting), Estimated PCD: 2023-07-16
Product
COVID-19 vaccinationClinical trial
A Phase I/II, Double-blind, Randomized, Active-controlled, Age De-escalation Trial to Assess Safety and Immunogenicity of a Measles Rubella Vaccine (MRV) Microneedle Patch (MRV-MNP) in Adults, MRV-primed Toddlers, and MRV-naïve InfantsStatus: Completed, Estimated PCD: 2022-11-23
Product
Measles Rubella VaccineProduct
MRV-MNPClinical trial
Safety and Immunogenicity of the SARS-CoV2 Vaccine in Solid Organ Transplantation (Lung and / or Liver) Adult RecipientsStatus: Completed, Estimated PCD: 2022-12-30
Product
COVID19 mRNA vaccineClinical trial
Clinical Phenotype of Persons Vaccinated Against Sars-CoV-2 Hospitalized for COVID-19 Disease as a Basis for Optimalization of National Vaccination Strategy and Post-exposure ProphylaxisStatus: Completed, Estimated PCD: 2023-11-30
Product
VaccionationClinical trial
Effect of Health Education on Promoting Influenza Vaccination Health Literacy Among Primary School StudentsStatus: Recruiting, Estimated PCD: 2024-06-30
Product
Health educationClinical trial
Efficacy of COVID-19 Booster-Dose Vaccine for Re-infection Precaution and Dynamics of Specific Serum Antibodies in the Management of Lung Cancer Patients With Systemic Anti-cancer TreatmentStatus: Recruiting, Estimated PCD: 2026-12-08
Product
COVID-19 Booster VaccineClinical trial
Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis: A Randomized-controlled TrialStatus: Recruiting, Estimated PCD: 2025-03-01
Product
HAVRIXClinical trial
Intradermal Administration of a COVID-19 mRNA Vaccine in ElderlyStatus: Terminated, Estimated PCD: 2024-03-21
Product
ComirnatyClinical trial
Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIVStatus: Recruiting, Estimated PCD: 2026-03-31
Clinical trial
A Prospective Cohort Study of Efficacy, Safety and Characterization of Immune Response to Vaccinations in Hematopoietic Stem Cell Transplant RecipientsStatus: Completed, Estimated PCD: 2021-01-21
Product
Immune BiomarkersClinical trial
A Multinational, Phase 2, Randomised, Adaptive Protocol to Evaluate Immunogenicity and Reactogenicity of Different COVID-19 Vaccines Administration in Older Adults (≥75) Already Vaccinated Against SARS-COV-2 (EU-COVAT-1_AGED)Status: Completed, Estimated PCD: 2022-10-01
Product
Comirnaty(BTN162b2)Product
SpikevaxClinical trial
Use of Virtual Reality in the Reduction of Pain After the Administration of Vaccines Among Children in Primary Care Centers.Status: Completed, Estimated PCD: 2024-01-24
Clinical trial
Double-blind Comparative Randomized Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro Tetravalent Inactivated Split Influenza Vaccine, Solution for Intramuscular Injection, FSUE SPbSRIVS FMBA of Russia, in Volunteers Aged 18-60 YearsStatus: Completed, Estimated PCD: 2020-12-08
Product
Influenza vaccineClinical trial
The Influence of Trained Immunity in COVID-19 Vaccinated IndividualsStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma: a Phase II StudyStatus: Recruiting, Estimated PCD: 2025-07-01
Product
TMZClinical trial
Maternal Determinants of Infant Immunity to PertussisStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Product
BoostrixProduct
Hexyon